Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-05-08
2007-05-08
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S139000
Reexamination Certificate
active
10820904
ABSTRACT:
The invention relatests compound of formula (I):wherein:n is 1, 2 or 3,A represents a groupX represents N or NR1,R2represents an alkoxy, cycloalkyloxy or cycloalkylalkyloxy group.and medicinal products containing the same which are useful in treading or in preventing melatoninergic disorder.
REFERENCES:
patent: 5116986 (1992-05-01), Bomhard et al.
Li, et al.,Drugs of the Future, 2000, 25, 945-957.
Krause, et al.,Society for Neuroscience, 1996, 22, No. 651.19, p. 1400.
Vacas, et al.,J. Pineal Research, 1992, 13, 60-65.
Cagnacci, et al.,J. Pineal Research, 1997, 22, 16-19.
Lagneux, et al.,Life Sciences, 2000, 66, 503-509.
Brydon, et al.,Endocrinology, 2001, 142, 4264-4271.
Bylesjö, et al.,International Journal of Eating Disorders, 1996, 20, 443-446.
Ferrari, et al.,Biol. Psychiatry, 1990, 27, 1007-1020.
Mazzucchelli, et al.,Molecular Brain Research, 1996, 39, 117-126.
Brown,CNS Drugs, 1995, 3, 209-226.
Waldhauser, et al.,Psychopharmacology, 1990, 100, 222-226.
Skene, et al.,Brain Research, 1990, 528, 170-174.
Monteleone, et al.,Schizophrenia Research, 1992, 7, 77-84.
Mc Intyre, et al.,Journal of Affective Disorders, 1987, 12, 203-206.
Erlich, et al.,J. Neurosurg., 1985, 63, 321-341.
Maurizi,Medical Hypotheses, 27, 271-276.
Kopp, et al.,Behavioural Pharmacology, 1999, 10, 73-83.
Kopp, et al.,Neuorpharmacology, 2000, 39, 1865-1871.
Fanteck, et al.,Exp. Brain Res., 1995, 107, 321-325.
Rasmussen et al.,Endocrinology, 1999, 140, 1009-1012.
Armstrong, et al.,Medical Hypotheses, 1991, 34, 300-309.
O'Brien, et al.,Clinical Endocrinology, 1986, 24, 359-364.
Motilva, et al.,Current Pharmaceutical Design, 2001, 7, 909-931.
Tamarkin, et al.,Science, 1985, 227, 714-720.
Chemineau, et al.,Rec. Med. Vet., 1991, 167, 227-239.
Xu, et al.,Drug Development Research, 1996, 39, 167-173.
Rėgrigny, et al.,Am. J. Physiol., 1998, 275, 139-144.
Stankov, et al.,Neuroscience, 1993, 52, 459-468.
Leone, et al.,Cephalalgia, 1996, 16, 494-496.
Brun, et al.,Cephalalgia, 1995, 15, 136-139.
Ying, et al.,Eur. J. of Pharmacology, 1993, 246, 89-96.
Laudon, et al.,Journal of Clinical Endocrinology and Metabolism, 1996, 81, 1336-1342.
Lissoni, et al.,British Journal of Cancer, 1996, 74, 1466-1468.
Audinot Valerie
Bennejean Caroline
Boutin Jean Albert
Delagrange Philippe
Gasnereau Anne
Davis Zinna N.
Hueschen and Sage
Les Laboratoires Servier
LandOfFree
Isoquinoline compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoquinoline compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoquinoline compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3758092